The helicobacter pylori non-invasive testing market is projected to grow from USD 1,188.6 million in 2025 to USD 1,828.3 million by 2035, at a CAGR of 4.4%. Serology Test will dominate with a 41.7% market share, while laboratory-based tests will lead the test type segment with a 54.2% share.